FindTrial
Sign In

Study for rhabdomyosarcoma and other malignant soft tissue tumours of childhood

Study for rhabdomyosarcoma and other malignant soft tissue tumours of childhood

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15121868
Enrollment
Unknown
Registered
2001-07-01
Start date
1995-07-01
Completion date
Unknown
Last updated
2019-02-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, soft tissue Cancer Malignant neoplasm of other connective and soft tissue

Interventions

High risk non metastatic patients are randomised to one of two treatment groups: 1. Group A: Chemotherapy with ifosfamide, vincristine and actinomycin D (IVA) 2. Group

Sponsors

Cancer Research UK (CRUK) (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Soft tissue sarcoma at one of the following sites: Vagina - Uterus - Paratestis - Orbit - Head and Neck - Bladder - Prostate - Limbs 2. Histological types: Rhabdomyosarcoma - Embryonal sarcoma - Undifferentiated sarcoma - Extra osseous Ewing's sarcoma - Soft tissue primitive neuroectodermal tumours 3. Stages I and II 4. Aged 6 months to 18 years 5. Less than 8 weeks since diagnostic biopsy

Exclusion criteria

Exclusion criteria: Does not match inclusion criteria

Design outcomes

Primary

MeasureTime frame
Not provided at time of registration—

Secondary

MeasureTime frame
Not provided at time of registration—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026